Latest Pharmacy biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Biotechnology is behind more than 40% of the active ingredients in medications included in the list of essential drugs in Europe

by Asebio

5 months ago
biotechnology

Over the last 40 years, biotechnology has shaped the landscape of medicine, as evidenced by the fact that 69% of drugs in development are a result of biotechnological advancements.

3P Biopharmaceuticals: forjando un legado de innovación y excelencia en biotecnología

by 3P Biopharmaceuticals

4 months ago
3P Biopharmaceuticals

La empresa recibe el premio a la Mejor Trayectoria Viveros CEIN en el Congreso Internacional de Emprendimiento de Alto Impacto

ORYZON entre las 1000 empresas europeas con mayor inversión en I+D

by Oryzon Genomics

4 months ago
Oryzon Genomics S.A.

Oryzon Genomics S.A. se complace en compartir que, de acuerdo al ranking publicado por la Unión Europea, se encuentra entre las 1000 empresas europeas con mayor inversión en I+D, en concreto en la p...

ORYZON to provide corporate progress updates at several events in January

by Oryzon Genomics

4 months ago
Oryzon Genomics S.A.

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...

Vall d'Hebron receives 2.6 million euros for research into advanced therapies

by Vall d’Hebron

3 months ago
CERTERA, advanced therapies

CERTERA's objective is to create a coordinated research and innovation structure to accelerate the preclinical and early stage clinical development of these types of therapies.

3P Biopharmaceuticals y Biovian se unen para formar 3PBIOVIAN, una CDMO de medicamentos biológicos líder en Europa

by 3P Biopharmaceuticals

3 months ago
3P Biopharmaceuticals, Biovian, 3PBIOVIAN

The combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...

ORYZON to provide corporate progress updates at several events in February-March

by Oryzon Genomics

Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing

by Thermo Fisher Scientific

2 months ago
Mycoplasma

This new service, offered by the analytical testing service of the clinical research business, ensures biopharmaceutical products are free of contaminants, helping customers deliver safe medicines for...

UPV develops a computational simulation methodology to identify the optimal drug dose to prevent arrhythmias

by Universitat Politècnica de València

2 months ago
Torsade de Pointes

It has been has developed a computational simulation methodology to assess the risk of different drugs inducing cardiac arrhythmias, specifically Torsade de Pointes, as a side effect.

The PROSPLIGN project: Fundacion MEDINA participates as a partner in the launch of a €3.4 Million Project on Lignin Bioprospecting

by MEDINA

2 months ago
lignin, PROSPLIGN project

The key project objective is to apply state-of-the-art methodologies to prospect the bioactivity potential of lignin – a natural, abundant and sustainable biopolymer component of lignocellulosic bio...

Rethinking clinical trial design for rare tumors

by VHIO

2 months ago
gastrointestinal stromal tumor (GIST)

In an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...

Mikrobiomik presenta el primer 'antibiótico no antibiótico'

by Professional Newco

2 months ago
microbiota intestinal, MBK-01

El medicamento biológico basado en microbiota intestinal MBK-01 trata a pacientes infectados con Clostridioides difficile, enfermedad que causa episodios muy graves de diarrea y que puede ser motivo ...